Testicular quantitative ultrasound: A noninvasive monitoring method for evaluating spermatogenic function in busulfan-induced testicular injury mouse models

Andrologia. 2021 Mar;53(2):e13927. doi: 10.1111/and.13927. Epub 2020 Dec 23.

Abstract

Busulfan-induced testicular injury mouse models are commonly used for experiments on spermatogonial stem cell transplantation, treatments for azoospermia due to spermatogenic failure and preserving male fertility after chemotherapy. Here, we investigated the value of testicular quantitative ultrasound for evaluating spermatogenic function in this model. In this study, testicular ultrasound was performed on mice from day 0 to 126 after busulfan treatment (n = 48), and quantitative data, including the testicular volume, mean pixel intensity and pixel uniformity, were analysed. The results revealed that from day 0 to 36, the testicular volume was positively associated with the testicle-to-body weight ratio (r = .92). On day 63, the pixel uniformity, which remained stable from day 0 to 36, declined significantly compared with that on day 36 (p < .01). On day 126, when the whole progression of spermatogenesis could be observed in most tubules, the mean pixel intensity also returned to normal (p > .05). In conclusion, testicular quantitative ultrasound could be used as a noninvasive and accurate monitoring method for evaluating spermatogenic function in busulfan-induced testicular injury mouse models.

Keywords: busulfan; noninvasive monitoring method; spermatogenic function; testicular ultrasound.

MeSH terms

  • Animals
  • Azoospermia* / chemically induced
  • Azoospermia* / diagnostic imaging
  • Busulfan / toxicity
  • Humans
  • Male
  • Mice
  • Spermatogenesis
  • Spermatogonia
  • Testis* / diagnostic imaging

Substances

  • Busulfan